As of 2026-01-02, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 7.0x | 5.7x |
| Forward P/E multiples | 5.9x - 7.7x | 7.1x |
| Fair Price | (9.97) - (11.90) | (10.79) |
| Upside | -747.4% - -873.0% | -800.9% |
| Date | EV/EBITDA |